Mutasi Isocitrate Dehydrogenase 1 dan 2 pada Glioma
Klasifikasi tumor sistem saraf pusat WHO terakhir didasarkan atas histogenesis tumor dan karakteristik molekuler genetik. Perubahan klasifikasi yang paling signifikan terjadi pada tumor glioma difus yang paling signifikan, yaitu katagori tumor secara garis besar berdasarkan status mutasi isocitrate...
Main Author: | Ni Putu Sriwidyani |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Udayana
2020-12-01
|
Series: | JBN (Jurnal Bedah Nasional) |
Online Access: | https://ojs.unud.ac.id/index.php/jbn/article/view/66821 |
Similar Items
-
How robust are the data in vorasidenib for isocitrate dehydrogenase-1 or isocitrate dehydrogenase-2 mutant low-grade glioma?
by: Eric T Wong
Published: (2023-01-01) -
Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01) -
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
by: Yang Liu, et al.
Published: (2020-08-01) -
Immunotherapy Approaches in Isocitrate-Dehydrogenase-Mutant Low-Grade Glioma
by: Marco Gallus, et al.
Published: (2023-07-01) -
Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma
by: Dongming Yan, et al.
Published: (2022-06-01)